Notch1 contributes to chemoresistance to gemcitabine and serves as an unfavorable prognostic indicator in pancreatic cancer

World Journal of Surgery

Volumn 37, Issue 7, 2013, Pages 1688-1694

  Du, Xiao ^a   Zhao, Yu Pei ^a   Zhang, Tai Ping ^a   Zhou, Li ^a   Chen, Ge ^a   Cui, Quan Cai ^a   Shi, Jie ^a   Wang, Tian Xiao ^a   You, Lei ^a   Shu, Hong ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC ANTIMETABOLITE; DEOXYCYTIDINE; GEMCITABINE; NOTCH1 PROTEIN, HUMAN; NOTCH1 RECEPTOR; TUMOR MARKER; DRUG DERIVATIVE;

ADULT; AGED; ANALOGS AND DERIVATIVES; CARCINOMA, PANCREATIC DUCTAL; DRUG RESISTANCE; EVALUATION STUDY; FEMALE; FOLLOW UP; GENE SILENCING; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; METASTASIS; MIDDLE AGED; MORTALITY; PANCREATIC NEOPLASMS; PATHOLOGY; PHYSIOLOGY; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL; TREATMENT OUTCOME; TUMOR CELL LINE; VERY ELDERLY; ARTICLE; PANCREAS CARCINOMA; PANCREAS TUMOR;

ADULT; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; CARCINOMA, PANCREATIC DUCTAL; CELL LINE, TUMOR; DEOXYCYTIDINE; DRUG RESISTANCE, NEOPLASM; FEMALE; FOLLOW-UP STUDIES; GENE KNOCKDOWN TECHNIQUES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PANCREATIC NEOPLASMS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, NOTCH1; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84879799772     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-013-2010-0     Document Type: Article

References (29)

1. Jemal A, Siegel R, Xu J et al (2010) Cancer statistics, 2010. CA Cancer J Clin 60:277-300
2. Gillen S, Schuster T, Meyer Zum Buschenfelde C et al (2010) Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages. PLoS Med 7:e1000267
3. Hidalgo M (2010) Pancreatic cancer. N Engl J Med 362:1605-1617
4. Shrikhande SV, Kleeff J, Reiser C et al (2007) Pancreatic resection for M1 pancreatic ductal adenocarcinoma. Ann Surg Oncol 14:118-127
5. Burris HA 3rd, Moore MJ, Andersen J et al (1997) Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15:2403-2413
6. Xie DR, Yang Q, Chen DL et al (2010) Gemcitabine-based cytotoxic doublets chemotherapy for advanced pancreatic cancer: updated subgroup meta-analyses of overall survival. Jpn J Clin Oncol 40:432-441
7. Tien AC, Rajan A, Bellen HJ (2009) A Notch updated. J Cell Biol 184:621-629
8. Ranganathan P, Weaver KL, Capobianco AJ (2011) Notch signalling in solid tumours: a little bit of everything but not all the time. Nat Rev Cancer 11:338-351
9. Takebe N, Harris PJ, Warren RQ et al (2011) Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways. Nat Rev Clin Oncol 8:97-106
10. Miyamoto Y, Maitra A, Ghosh B et al (2003) Notch mediates TGF alpha-induced changes in epithelial differentiation during pancreatic tumorigenesis. Cancer Cell 3:565-576
11. Buchler P, Gazdhar A, Schubert M et al (2005) The Notch signaling pathway is related to neurovascular progression of pancreatic cancer. Ann Surg 242:791-800
12. Wang Z, Banerjee S, Li Y et al (2006) Down-regulation of notch-1 inhibits invasion by inactivation of nuclear factor-kappaB, vascular endothelial growth factor, and matrix metalloproteinase-9 in pancreatic cancer cells. Cancer Res 66:2778-2784
13. Wang Z, Zhang Y, Li Y et al (2006) Down-regulation of Notch-1 contributes to cell growth inhibition and apoptosis in pancreatic cancer cells. Mol Cancer Ther 5:483-493
14. Kimura K, Satoh K, Kanno A et al (2007) Activation of Notch signaling in tumorigenesis of experimental pancreatic cancer induced by dimethylbenzanthracene in mice. Cancer Sci 98:155-162
15. De La OJ, Emerson LL, Goodman JL et al (2008) Notch and Kras reprogram pancreatic acinar cells to ductal intraepithelial neoplasia. Proc Natl Acad Sci U S A 105:18907-18912
16. Mullendore ME, Koorstra JB, Li YM et al (2009) Ligand-dependent Notch signaling is involved in tumor initiation and tumor maintenance in pancreatic cancer. Clin Cancer Res 15:2291-2301
17. Ristorcelli E, Beraud E, Mathieu S et al (2009) Essential role of Notch signaling in apoptosis of human pancreatic tumoral cells mediated by exosomal nanoparticles. Int J Cancer 125:1016-1026
18. Bao B, Wang Z, Ali S et al (2011) Notch-1 induces epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells. Cancer Lett 307:26-36
19. Hanlon L, Avila JL, Demarest RM et al (2010) Notch1 functions as a tumor suppressor in a model of K-ras-induced pancreatic ductal adenocarcinoma. Cancer Res 70:4280-4286
20. Mazur PK, Einwachter H, Lee M et al (2010) Notch2 is required for progression of pancreatic intraepithelial neoplasia and development of pancreatic ductal adenocarcinoma. Proc Natl Acad Sci U S A 107:13438-13443
21. Vizio B, Mauri FA, Prati A et al (2012) Comparative evaluation of cancer stem cell markers in normal pancreas and pancreatic ductal adenocarcinoma. Oncol Rep 27:69-76
22. Cheung HC, Corley LJ, Fuller GN et al (2006) Polypyrimidine tract binding protein and Notch1 are independently re-expressed in glioma. Mod Pathol 19:1034-1041
23. Murtaugh LC, Stanger BZ, Kwan KM et al (2003) Notch signaling controls multiple steps of pancreatic differentiation. Proc Natl Acad Sci U S A 100:14920-14925
24. Yao J, Qian C (2009) Inhibition of Notch3 enhances sensitivity to gemcitabine in pancreatic cancer through an inactivation of PI3 K/Akt-dependent pathway. Med Oncol 27:1017-1022
25. Ansari D, Rosendahl A, Elebro J et al (2011) Systematic review of immunohistochemical biomarkers to identify prognostic subgroups of patients with pancreatic cancer. Br J Surg 98:1041-1055
26. Chu D, Zhang Z, Zhou Y et al (2011) Notch1 and Notch2 have opposite prognostic effects on patients with colorectal cancer. Ann Oncol 22:2440-2447
27. Reedijk M, Odorcic S, Chang L et al (2005) High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival. Cancer Res 65:8530-8537
28. Donnem T, Andersen S, Al-Shibli K et al (2010) Prognostic impact of Notch ligands and receptors in nonsmall cell lung cancer: coexpression of Notch-1 and vascular endothelial growth factor-A predicts poor survival. Cancer 116:5676-5685
29. Chang HH, Lee H, Hu MK et al (2010) Notch1 expression predicts an unfavorable prognosis and serves as a therapeutic target of patients with neuroblastoma. Clin Cancer Res 16:4411-4420